IMMX Immix Biopharma, Inc.

Fundamentals / CIK 0001873835 / USD

Immix Biopharma, Inc. reported $345.9M in total assets and a net loss of $46.22M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open IMMX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$27.49MFY 2020 Net Income: -$1.15M2020FY 2021 Net Income: -$24.38M2021FY 2022 Net Income: -$8.23M2022FY 2023 Net Income: -$15.43M2023FY 2024 Net Income: -$21.61M2024FY 2025 Net Income: -$29.40M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $16.26M $11.29M $8.74M $4.20M $127K $248K
Total Operating Expenses $29.96M $22.67M $16.14M $8.22M $1.35M $454K
Operating Income -$29.96M -$22.67M -$16.14M -$8.22M -$1.35M -$454K
EBITDA -$29.71M -$22.64M -$16.14M -$8.22M -$1.35M -$452K
Interest Income $556K $1.02M $572K -- -- --
Interest Expense -- -- -- $497 $180K $102K
Income Before Tax -$29.40M -$21.66M -$15.57M -$8.22M -$24.38M -$1.13M
Income Tax Expense $38K $41K $26K $10K $6.0K $18K
Net Income -$29.40M -$21.61M -$15.43M -$8.23M -$24.38M -$1.15M
Basic EPS -$0.89 -$0.76 -$0.89 -$0.59 -$6.64 -$0.34
Diluted EPS -$0.89 -$0.76 -$0.89 -$0.59 -$6.64 -$0.34
Basic Shares Outstanding 33.0M 28.3M 17.3M 13.9M 3.7M 3.4M
Diluted Shares Outstanding 33.0M 28.3M 17.3M 13.9M 3.7M 3.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $5.54M $5.33M $5.98M $5.73M $4.58M $3.97M $1.98M $1.37M
Total Operating Expenses $15.95M $12.46M $10.80M $10.89M $7.66M $6.72M $4.68M $4.99M
Operating Income -$15.95M -$12.46M -$10.80M -$10.89M -$7.66M -$6.72M -$4.68M -$4.99M
EBITDA -$15.85M -$12.37M -$10.71M -$10.84M -$7.57M -$6.66M -$4.64M -$4.97M
Interest Income $2.02M $914K $717K $217K $85K $104K $150K $186K
Income Before Tax -$13.93M -$11.54M -$10.09M -$10.68M -$7.58M -$6.61M -$4.53M -$4.80M
Income Tax Expense -- $14K -- $11K $7.7K $8.9K $9.8K $11K
Net Income -$13.93M -$11.56M -$10.09M -$10.65M -$7.59M -$6.62M -$4.54M -$4.81M
Basic EPS -$0.19 -$0.18 -$0.18 -- -$0.24 -$0.22 -$0.15 --
Diluted EPS -$0.19 -$0.18 -$0.18 -- -$0.24 -$0.22 -$0.15 --
Basic Shares Outstanding 74.1M 63.8M 55.4M -- 31.9M 30.0M 29.7M --
Diluted Shares Outstanding 74.1M 63.8M 55.4M -- 31.9M 30.0M 29.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $93.93M $17.68M $17.51M $13.44M $17.64M $391K
Short-Term Investments $6.48M -- -- -- -- --
Cash & Short-Term Investments $100.4M $17.68M $17.51M $13.44M $17.64M $391K
Other Current Assets $151K $32K $45K $78K -- --
Total Current Assets $101.2M $20.20M $19.79M $14.90M $18.19M $532K
Property, Plant & Equipment, Net $2.52M $1.74M $50K $3.6K $5.7K $7.4K
Other Non-Current Assets $20K $20K -- $6.7K -- --
Total Non-Current Assets $3.60M $2.75M $137K $10K $5.7K $7.4K
Total Assets $104.8M $22.95M $19.93M $14.91M $18.19M $540K
Accounts Payable $5.44M $5.39M $1.43M $143K -- --
Total Current Liabilities $10.11M $8.69M $3.72M $1.27M $202K $5.27M
Total Non-Current Liabilities $934K $1.01M $0 $475K $0 $0
Total Liabilities $11.04M $9.70M $3.72M $1.75M $202K $5.27M
Total Debt (incl. Leases) $1.07M $1.07M -- -- -- --
Common Stock $5.3K $2.8K $2.0K $1.4K $1.3K $338
Retained Earnings -$104.5M -$75.02M -$53.41M -$37.99M -$29.76M -$5.37M
Accumulated Other Comp. Income $60K -$1.1K $135K $87K $125K $132K
Total Stockholders' Equity $93.80M $13.25M $16.41M $13.16M $17.99M -$4.73M
Total Equity $93.80M $13.25M $16.20M $13.16M $17.99M -$4.73M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $320.3M $225.5M $79.25M $93.93M $15.95M $11.64M $15.92M $17.68M
Short-Term Investments $15.99M $6.62M $11.33M $6.48M -- -- -- --
Cash & Short-Term Investments $336.3M $232.1M $90.60M $100.4M $15.95M $11.64M $15.92M $17.68M
Other Current Assets $115K $279K $336K $151K $133K $138K $168K $32K
Total Current Assets $338.1M $233.8M $92.27M $101.2M $16.58M $12.33M $16.78M $20.20M
Property, Plant & Equipment, Net $2.41M $2.36M $2.43M $2.52M $2.36M $2.23M $2.12M $1.74M
Long-Term Investments $4.57M $2.05M -- -- -- -- -- --
Other Non-Current Assets $20K $20K $20K $20K $20K $20K $20K $20K
Total Non-Current Assets $7.87M $5.32M $3.54M $3.60M $3.50M $3.31M $3.11M $2.75M
Total Assets $345.9M $239.1M $95.82M $104.8M $20.08M $15.64M $19.89M $22.95M
Accounts Payable $5.60M $5.28M $4.73M $5.44M $7.05M $6.61M $5.74M $5.39M
Total Current Liabilities $10.03M $9.30M $10.54M $10.11M $10.85M $10.01M $9.31M $8.69M
Total Non-Current Liabilities $869K $891K $912K $934K $965K $972K $991K $1.01M
Total Liabilities $10.89M $10.19M $11.45M $11.04M $11.82M $10.98M $10.30M $9.70M
Total Debt (incl. Leases) $965K $1.00M $1.04M $1.07M $1.11M $1.04M $1.06M $1.07M
Common Stock $8.4K $7.2K $5.3K $5.3K $3.3K $2.8K $2.8K $2.8K
Retained Earnings -$140.0M -$126.1M -$114.5M -$104.5M -$93.78M -$86.19M -$79.57M -$75.02M
Accumulated Other Comp. Income $6.4K $119K $106K $60K $62K $65K $15K -$1.1K
Total Stockholders' Equity $335.1M $228.9M $84.36M $93.80M $8.26M $4.65M $9.59M $13.25M
Total Equity $335.1M $228.9M $84.36M $93.80M $8.26M $4.65M $9.59M $13.25M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$29.44M -$21.70M -$15.60M -$8.23M -$24.38M -$1.15M
Depreciation & Amortization $246K $33K $5.5K $2.1K $2.5K $2.3K
Stock-Based Compensation $2.44M $3.02M $2.57M $624K $219K --
Operating Cash Flow -$23.93M -$14.60M -$11.37M -$7.41M -$1.59M -$405K
Capital Expenditure -$733K -$1.18M -$52K -- -$802 --
Free Cash Flow -$24.66M -$15.77M -$11.42M -- -$1.59M --
Investing Cash Flow -$7.21M -$1.18M -$52K -- -$802 --
Common Stock Issued $107.4M $15.95M $15.52M $2.91M $18.65M --
Share Repurchases -- -- -- -$100K -- --
Financing Cash Flow $107.4M $15.95M $15.46M $3.23M $18.85M --
Net Change in Cash $76.25M $172K $4.07M -$4.21M $17.25M -$343K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$13.93M -$11.56M -$10.10M -$10.69M -$7.59M -$6.62M -$4.54M -$4.81M
Depreciation & Amortization $94K $91K $92K $52K $97K $58K $38K $21K
Stock-Based Compensation $1.29M $978K $576K $571K $470K $532K $868K $706K
Operating Cash Flow -$12.31M -$11.74M -$9.83M -$11.03M -$5.91M -$5.31M -$1.69M -$1.48M
Capital Expenditure -$121K -$21K -$32K -$165K -$372K -$128K -$68K -$507K
Free Cash Flow -$12.43M -$11.76M -$9.86M -$11.19M -$6.28M -$5.44M -$1.75M -$1.98M
Investing Cash Flow -$12.03M $2.67M -$4.80M -$6.65M -$372K -$128K -$68K -$507K
Common Stock Issued -- -- -- -- -- -- -- $0
Financing Cash Flow $119.2M $155.3M -$38K -- -- -- -- $0
Net Change in Cash $94.82M $146.2M -$14.68M $77.98M $4.31M -$4.28M -$1.76M -$2.01M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -31.3% -163.1% -94.0% -62.5% -135.5% --
Return on Assets (ROA) -28.0% -94.2% -77.4% -55.2% -134.0% -212.7%
Current Ratio 10.01x 2.33x 5.32x 11.70x 90.01x 0.10x
Quick Ratio 9.93x 2.04x 4.70x 10.55x 87.33x 0.07x
Debt to Equity 0.01x 0.08x -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -13.8% -17.4% -41.4% -31.3% -285.1% -497.0% -217.8% -163.1%
Return on Assets (ROA) -13.4% -16.7% -36.5% -28.0% -117.3% -147.9% -105.1% -94.2%
Current Ratio 33.72x 25.13x 8.76x 10.01x 1.53x 1.23x 1.80x 2.33x
Quick Ratio 33.55x 24.95x 8.60x 9.93x 1.47x 1.16x 1.71x 2.04x
Debt to Equity 0.00x 0.00x 0.01x 0.01x 0.13x 0.22x 0.11x 0.08x
Source: SEC EDGAR CompanyFacts (CIK 0001873835) · from December 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:33 UTC · Open in terminal